Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 25 Apr 2024 12:55 CEST |
BERGENBIO | BerGenBio ASA: New share capital registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 17 Apr 2024 17:10 CEST |
BERGENBIO | BerGenBio ASA: Resolution to increase the share capital for settlement of underwriting commission | 20103010 Biotechnology | Total number of voting rights and capital |
| 17 Apr 2024 09:42 CEST |
BERGENBIO | BerGenBio - Disclosure of shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 17 Apr 2024 08:16 CEST |
BERGENBIO | BerGenBio - Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 16 Apr 2024 14:15 CEST |
BERGENBIO | BerGenBio ASA: Final results for the last exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Apr 2024 10:58 CEST |
BERGENBIO | BerGenBio ASA: Mandatory notification of trade by primary insiders and close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 15 Apr 2024 07:00 CEST |
BERGENBIO | BerGenBio ASA: Siste dag av den siste utøvelsesperioden for de frittstående tegningsrettene utstedt i forbindelse med fortrinnsrettsemisjonen | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 15 Apr 2024 07:00 CEST |
BERGENBIO | BerGenBio ASA: Last day of the last exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Apr 2024 07:15 CEST |
BERGENBIO | BerGenBio ASA: Last day of trading in warrants | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Apr 2024 07:00 CEST |
BERGENBIO | Mandatory notification of trade by related party to Primary Insiders | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 03 Apr 2024 13:22 CEST |
BERGENBIO | BerGenBio ASA: Information about the last exercise period for Warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 02 Apr 2024 08:50 CEST |
BERGENBIO | BerGenBio ASA: Commencement of the last exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 02 Apr 2024 08:50 CEST |
BERGENBIO | BerGenBio ASA: Start av den siste utøvelsesperioden for de frittstående tegningsrettene utstedt i forbindelse med fortrinnsrettsemisjonen | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 02 Apr 2024 07:55 CEST |
BERGENBIO | BerGenBio ASA secures underwriting of NOK 118 million gross proceeds representing minimum 80% exercise of the remaining Warrants, providing funding into 2H 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Mar 2024 15:59 CET |
BERGENBIO | BerGenBio ASA: Exercise price in the last exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 Mar 2024 17:15 CET |
BERGENBIO | BerGenBio Announces Initiation of Phase 2a in First Line Non-Small Lung Cancer Patients with a STK11 mutation | 20103010 Biotechnology | Inside information |
| 04 Mar 2024 07:00 CET |
BERGENBIO | BerGenBio to Participate in Carnegie Nordic Healthcare Seminar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Feb 2024 17:58 CET |
BERGENBIO | BerGenBio ASA - Approval and publication of a prospectus supplement | 20103010 Biotechnology | Prospectus / admission document |
| 14 Feb 2024 07:00 CET |
BERGENBIO | BerGenBio's Fourth Quarter 2023 Results: Focused Strategy Gathers Momentum | 20103010 Biotechnology | Inside information |
| 14 Feb 2024 07:00 CET |
BERGENBIO | BerGenBios resultater for fjerde kvartal 2023: Fokusert strategi gir momentum | 20103010 Biotechnology | Innsideinformasjon |
| 07 Feb 2024 12:00 CET |
BERGENBIO | BerGenBio Announces New Preclinical Data Indicating Broadened Potential for Bemcentinib to Treat Severe Respiratory Infections | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Feb 2024 07:00 CET |
BERGENBIO | BerGenBio ASA: Invitation to fourth quarter 2023 results webcast | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 05 Jan 2024 17:14 CET |
BERGENBIO | BerGenBio ASA – Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 15 Dec 2023 16:48 CET |
BERGENBIO | BerGenBio announces closure of EU-SolidAct bemcentinib study arm in hospitalized COVID-19 patients | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Dec 2023 07:00 CET |
BERGENBIO | BerGenBio to Present at DNB Nordic Healthcare Conference | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Dec 2023 07:00 CET |
BERGENBIO | BerGenBio Announces Final Bemcentinib Phase 2 Data in AML and MDS Presented at the 2023 ASH Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Dec 2023 18:10 CET |
BERGENBIO | BerGenBio ASA: Grant of share options | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 08 Dec 2023 08:33 CET |
BERGENBIO | BerGenBio ASA - New share capital registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 07 Dec 2023 14:05 CET |
BERGENBIO | BerGenBio ASA: Approval and publication of prospectus | 20103010 Biotechnology | Prospectus / admission document |
| 07 Dec 2023 10:47 CET |
BERGENBIO | BerGenBio ASA - Updated timeline for delivery of new shares | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Nov 2023 17:30 CET |
BERGENBIO | BerGenBio ASA - Final results for the first exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Nov 2023 19:00 CET |
BERGENBIO | BerGenBio ASA - Preliminary results for the first exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Nov 2023 07:00 CET |
BERGENBIO | BerGenBio ASA - Last day of the first exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Nov 2023 07:00 CET |
BERGENBIO | BerGenBio ASA - Siste dag av den første utøvelsesperioden for de frittstående tegningsrettene utstedt i forbindelse med fortrinnsrettsemisjonen | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 24 Nov 2023 13:46 CET |
BERGENBIO | BerGenBio ASA - Information about the first exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Nov 2023 15:23 CET |
BERGENBIO | BerGenBio ASA Mandatory notification of trade by primary insiders and close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 15 Nov 2023 07:00 CET |
BERGENBIO | BerGenBio ASA - Commencement of the first exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Nov 2023 07:00 CET |
BERGENBIO | BerGenBio ASA - Start av den første utøvelsesperioden for de frittstående tegningsrettene utstedt i forbindelse med fortrinnsrettsemisjonen | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 14 Nov 2023 07:00 CET |
BERGENBIO | BerGenBio Reports Third Quarter 2023 Financial Results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Nov 2023 19:46 CET |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Nov 2023 12:00 CET |
BERGENBIO | BerGenBio ASA: Invitation to third quarter 2023 results webcast | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Nov 2023 07:00 CET |
BERGENBIO | BerGenBio Announces Data from Biomarker Analyses in 2L NSCLC | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 02 Nov 2023 14:00 CET |
BERGENBIO | BerGenBio Announces Poster Presentation at Upcoming ASH Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 31 Oct 2023 14:00 CET |
BERGENBIO | BerGenBio Announces Poster Presentation at Upcoming SITC Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Oct 2023 07:30 CEST |
BERGENBIO | New Data on BerGenBio's Selective AXL Inhibitor Bemcentinib Released Today at 2023 ESMO Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Oct 2023 07:00 CEST |
BERGENBIO | Additional data on BerGenBio's selective AXL inhibitor bemcentinib to be presented at the 2023 ESMO meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Sep 2023 07:00 CEST |
BERGENBIO | BerGenBio to Present Company Update at H.C. Wainright Annual Global Investment Conference | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Aug 2023 20:35 CEST |
BERGENBIO | Correction: BerGenBio ASA Seccond Quarter and half year 2023 Financial Report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 23 Aug 2023 07:00 CEST |
BERGENBIO | BerGenBio Reports Second Quarter 2023 Financial Results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 22 Aug 2023 10:30 CEST |
BERGENBIO | BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |